SAN FRANCISCO & DENVER--(BUSINESS WIRE)-- #AI--Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, announced today a strategic partnership to expand access to their technologies for coronary artery disease detection and risk assessment. The collaboration leverages both companies' FDA-cleared solutions to help health systems identify at-risk patients earlier and deliver comprehensive cardiovascular care. Bunkerhill's Careblocks